Amylyx Pharmaceuticals (AMLX) EBITDA Margin (QoQ) (2022 - 2024)
Amylyx Pharmaceuticals (AMLX) EBITDA Margin (QoQ) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | -731,931.00 |
| Mar 31, 2024 | -13,956.00 |
| Dec 31, 2023 | -1,645.00 |
| Sep 30, 2023 | -234.00 |
| Jun 30, 2023 | 2,344.00 |
| Mar 31, 2023 | 20,089.00 |
| Dec 31, 2022 | 1.56 Mn |